» Articles » PMID: 37223575

Impact of Different Health Warning Label and Reduced Exposure Messages in IQOS Ads on Perceptions Among US and Israeli Adults

Overview
Journal Prev Med Rep
Date 2023 May 24
PMID 37223575
Authors
Affiliations
Soon will be listed here.
Abstract

Heated tobacco products (HTPs; e.g., IQOS) are advertised as safer than cigarettes or an alternative, yet required health warning labels (HWLS) in many countries, including the US and Israel, do not consider whether HTP ads undermine HWLs, particularly those that do not explicitly address HTPs. In 2021, a randomized 4 × 3 factorial experiment among 2,222 US and Israeli adults examined IQOS ads with differing: 1) HWLs (i.e., smoking risks, prompt to quit, HTP-specific, control); and 2) ad messages (i.e., slight distancing: "cigarette-like satisfaction, no odor", clear distancing: "looking for an alternative?", control). Outcomes were perceived relative harm (vs cigarettes), exposure to harmful chemicals, and disease risk and likelihood of trying or suggesting IQOS to smokers. Ordinal logistic regression was used, adjusted for covariates. One HWL effect was found: risk (vs control) increased perceived relative harm (aOR = 1.21, CI = 1.03-1.41) and exposure (aOR = 1.22, CI = 1.04-1.42) and decreased likelihood of trying IQOS (aOR = 0.82, CI = 0.69-0.97). Both slight and clear distancing ads (vs control) decreased perceived harm (aOR = 0.85, CI = 0.75-0.97; aOR = 0.63, CI = 0.55-0.72, respectively) and increased likelihood of suggesting IQOS to smokers (aOR = 1.23, CI = 1.07-1.41; aOR = 1.28, CI = 1.11-1.47); slight distancing decreased perceived disease risk (aOR = 0.85, CI = 0.75-0.97); and clear distancing decreased perceived exposure (aOR = 0.73, CI = 0.64-0.83). Clear (vs slight) distancing decreased perceived relative harm (aOR = 0.74, CI = 0.65-0.85) and exposure (aOR = 0.82, CI = 0.71-0.93). One interaction effect was found: the quitting HWL and clear distancing led to particularly low perceived relative harm (aOR = 0.63, CI = 0.43-0.93). Regulatory agencies must monitor the impacts of advertising, including reduced risk/exposure messaging on perceptions of HWL messages, to inform future regulatory efforts.

Citing Articles

A Scoping Review of Behavioural Studies on Heated Tobacco Products.

Fearon I, Cordery S, Fitzpatrick M, Weaver S, Stevenson M, Grandolfo E Cureus. 2024; 16(7):e65773.

PMID: 39211653 PMC: 11361622. DOI: 10.7759/cureus.65773.


IQOS news media coverage in Israel: a comparison across three subpopulations.

Khayat A, Bar-Zeev Y, Kaufman Y, Berg C, Abroms L, Duan Z Tob Control. 2024; .

PMID: 39013604 PMC: 11735691. DOI: 10.1136/tc-2023-058422.


Heated tobacco product marketing: a mixed-methods study examining exposure and perceptions among US and Israeli adults.

Cui Y, Bar-Zeev Y, Levine H, LoParco C, Duan Z, Wang Y Health Educ Res. 2024; 39(4):375-397.

PMID: 38739472 PMC: 11258801. DOI: 10.1093/her/cyae018.


The impacts of electronic cigarette health warning labels on use intentions and perceptions: A cross-sectional study of US and Israeli adults who use tobacco.

Duan Z, Levine H, Bar-Zeev Y, Cui Y, LoParco C, Wang Y J Public Health Res. 2023; 12(4):22799036231214396.

PMID: 38020219 PMC: 10666698. DOI: 10.1177/22799036231214396.


Health warning labels on heated tobacco products and their impact on use intentions and risk perceptions: a cross-sectional study of adult tobacco users in the US and Israel.

Duan Z, Levine H, Bar-Zeev Y, Cui Y, LoParco C, Wang Y Isr J Health Policy Res. 2023; 12(1):33.

PMID: 37957696 PMC: 10644544. DOI: 10.1186/s13584-023-00582-9.

References
1.
Berg C, Romm K, Bar-Zeev Y, Abroms L, Klinkhammer K, Wysota C . IQOS marketing strategies in the USA before and after US FDA modified risk tobacco product authorisation. Tob Control. 2021; 32(4):418-427. PMC: 9016087. DOI: 10.1136/tobaccocontrol-2021-056819. View

2.
Max W, Sung H, Lightwood J, Wang Y, Yao T . Modelling the impact of a new tobacco product: review of Philip Morris International's Population Health Impact Model as applied to the IQOS heated tobacco product. Tob Control. 2018; 27(Suppl 1):s82-s86. PMC: 6240026. DOI: 10.1136/tobaccocontrol-2018-054572. View

3.
Hall M, Sheeran P, Noar S, Ribisl K, Boynton M, Brewer N . A brief measure of reactance to health warnings. J Behav Med. 2017; 40(3):520-529. PMC: 5458745. DOI: 10.1007/s10865-016-9821-z. View

4.
Yang B, Massey Z, Popova L . Effects of modified risk tobacco product claims on consumer comprehension and risk perceptions of IQOS. Tob Control. 2021; 31(e1):e41-e49. PMC: 8426425. DOI: 10.1136/tobaccocontrol-2020-056191. View

5.
Chen-Sankey J, Kechter A, Barrington-Trimis J, McConnell R, Krueger E, Cruz T . Effect of a hypothetical modified risk tobacco product claim on heated tobacco product use intention and perceptions in young adults. Tob Control. 2021; 32(1):42-50. PMC: 8630081. DOI: 10.1136/tobaccocontrol-2021-056479. View